Filtered By:
Education: Study
Vaccination: Hepatitis Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1696 results found since Jan 2013.
Prevalence of hepatitis B infection in the Gambian population: A narrative review of recent developments
This study reviewed the recent trends in the epidemiological characteristics of HBV in the Gambia. The researchers conducted an online literature search for primary studies on HBV prevalence published in the past two decades from Jan 1992 to Feb 2022 inclusive on Google Scholar, PubMed, and Scopus. All retrieved studies were assessed for eligibility according to specific inclusion/exclusion criteria, data completeness, and methodological coherence. We found that HBV infection prevalence is above 8% in The Gambia. Moreover, HBV is the most common cause of hepatocellular carcinoma (HCC) in Gambia. Liver cirrhosis and HCC hav...
Source: Cancer Control - September 18, 2023 Category: Cancer & Oncology Authors: Muhammed Camara Marcarious M Tantuoyir SeyedAhmad SeyedAlinaghi Fereshteh Ghiasvand Zahra Ahmadinejad Source Type: research
Assessment of Disease Burden and Immunization Rates for Vaccine-Preventable Diseases in People Living with HIV: The Korea HIV/AIDS Cohort Study
CONCLUSION: The burden of vaccine-preventable diseases was quite high in HIV-infected patients. Nadir CD4 T-cell counts, peak HIV viral loads, and the number of ART regimen change are significant factors related to vaccination. Considering the low vaccination rates for VPDs, there was a discordance between experts' opinions and real clinical practice in the medical field.PMID:37674339 | DOI:10.3947/ic.2023.0045
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Hye Seong Yunsu Choi Kyoung Hwan Ahn Jun Yong Choi Shin-Woo Kim Sang Il Kim Mee-Kyung Kee Bo Youl Choi Boyoung Park Hak Jun Hyun Jin Gu Yoon Ji Yun Noh Hee Jin Cheong Woo Joo Kim Joon Young Song Source Type: research
Immunogenicity and safety of Havisure < sup > TM < /sup > vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
CONCLUSION: The study results indicate that the Havisure™ vaccine is immunogenic and safe when administered to healthy subjects of 12 months to 49 years of age, and is non-inferior to Havrix® Vaccine.PMID:37661535 | DOI:10.1016/j.vaccine.2023.08.084
Source: Vaccine - September 4, 2023 Category: Allergy & Immunology Authors: Sai Krishna Susarla Madhu Gupta Kheya Ghosh Uttam Sonali Palkar Ashish Ramachandra Dhongade K Siva Ram Prasad Vasudev Rajapantula M D Ravi N Pradeep M Satish B C Rajashakar G Sandhya L Rajendra Devi Prasad Sahoo Anand Kumar Kanakasapapathy Source Type: research
Avian anti-HBV immunoglobulin: New tool to improve hepatitis B diagnosis methods
In conclusion, it was possible producing anti-HBs IgY by immunizing chickens with HBV vaccine; this molecule could be used as capture antibody to help detecting HBsAg in-house ELISA.PMID:37659497 | DOI:10.1016/j.ijbiomac.2023.126644
Source: International Journal of Biological Macromolecules - September 2, 2023 Category: Biochemistry Authors: Raissa Martins Deodato Debora Regina Lopes Dos Santos Mayara Torquato Lima da Silva Helena Medina Cruz Vanessa Salete de Paula Livia Melo Villar Source Type: research
Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen ®) vaccination on antibody titers; a japanese cross-sectional study
CONCLUSIONS: Three doses of Aimmugen® are efficacious, but four or more doses induce more robust and sustained antibody production. Additionally, four or more doses may be effective when there is a need to ensure long-term immunity or risk of prolonged exposure.PMID:37620202 | DOI:10.1016/j.vaccine.2023.08.030
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Yohei Maki Naoki Edo Makoto Mizuguchi Mikihito Ikeda Masato Kitano Etsuko Kitagami Morichika Osa Shotaro Yamamoto Takunori Ogawa Takahiro Nakamura Akihiko Kawana Yoshifumi Kimizuka Source Type: research
Viral Hepatitis in Pregnancy: ACOG Clinical Practice Guideline No. 6
Obstet Gynecol. 2023 Sep 1;142(3):745-759. doi: 10.1097/AOG.0000000000005300.ABSTRACTPURPOSE: The purpose of this document is to describe the specific types of viral hepatitis, their implications during pregnancy, the risk of perinatal transmission, and issues related to both treatment and prevention of infection.TARGET POPULATION: Pregnant or postpartum women and individuals who screen positive for viral hepatitis infection. The onset of these conditions may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum.METHODS: This guideline was developed using an a ...
Source: Obstetrics and Gynecology - August 17, 2023 Category: OBGYN Source Type: research
Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study
CONCLUSIONS: Our approach provides decision-makers with a valuable tool to better understand local patterns of untimely childhood vaccination and identify districts where strengthening vaccine delivery systems could have the greatest impact.PMID:37563051 | DOI:10.1016/j.vaccine.2023.08.004
Source: Vaccine - August 10, 2023 Category: Allergy & Immunology Authors: Oghenebrume Wariri Chigozie Edson Utazi Uduak Okomo C Jessica E Metcalf Malick Sogur Sidat Fofana Kris A Murray Chris Grundy Beate Kampmann Source Type: research
